Patient Advocacy + Virtual Summit
The Patient Advocacy + summit, organized by Swissnex is a series of workshops to help pharmaceutical executives and life science entrepreneurs understand the important role of patient advocacy in bringing about innovation, and insights for collaborating with nonprofits to accelerate product development for patients with unmet needs. Dave Bjork will be leading one of the workshops to share how FRAXA is collaborating with biopharma companies to advance treatment innovation for Fragile X syndrome. This event will give FRAXA exposure to biotech and pharma companies that may have an interest in Fragile X and other brain disorders.
Swissnex’s mission is to promote the exchange of great ideas, talent, and technology between Switzerland and North America. Many of the largest pharmaceutical companies are located in Switzerland.